Case Study- Broadway Medical Center

Home / Case Studies / Broadway Medical Center

Broadway Medical Center

Broadway Medical Clinic is a 35,419-square-foot, newly modernized medical facility located in Portland’s desirable Rose City Park submarket. The building underwent a full renovation in 2023, positioning it as a premier healthcare destination with efficient systems and long-term operational durability.

Soon after acquisition, BMC will be acquired by The Oregon Clinic, Oregon’s largest private multi-specialty physician group. This affiliation enhances tenant credit, strengthens stability, and anchors the property’s investment profile. This marks Prevail’s third venture with CrownMed, following two successful medical office partnerships (Edgewood and Flint Medical)—both tracking precisely to pro forma and consistently distributing cash flow to Prevail investors.

If you have any questions, please reach out to your advisor or contact Regan Smith at rsmith@prevailiws.com

Investor Return Summary*

Class A – Total of $3,500,000
- $250,000 per share
- 9% preferred return
- 22% – 24% LP Net IRR Targeted

Class B – Total of $2,500,000
- $100,000 per share
- 7.50% preferred return
- 20% – 22% LP Net IRR Targeted

Investment Snapshot

Purchase Price: $15,778,000

Loan Amount: $9,4700,000
- Loan to Cost: 60%
- Initial Terms: 5.75%
LP Equity: $6,308,000
- Prevail Equity: $3,000,000 (47.6%)

Property Information

Long-Term Stability: 15-year NNN lease with 3% annual rent growth ensures steady, inflation-protected cash flow.
Creditworthy Tenant: Imminent transition to The Oregon Clinic-an established, top-tier healthcare operator with deep market share across Oregon.
Modern Infrastructure: 2023 renovation delivers contemporary building systems, patient-ready spaces, and limited CapEx exposure for the foreseeable future.
Attractive Yield Profile: 7.25% + Cash Yield in Year 1 with a 5-Year Cash Yield Average of 7.35% and distributions beginning one month after closing.
Tax-Advantaged Return: A cost segregation and depreciation study is being completed that will enhance the 7.35% average return on a tax-advantaged basis.
Experienced Sponsor: Third partnership with CrownMed, a proven medical-office operator delivering steady investor returns.
Strategic Location: Situated in the Rose City Park medical corridor-proximate to hospitals, affluent residential areas, and major commuter routes-supporting tenant retention and value durability.

*These are all preliminary estimates, with no guarantee of performance, and involve risk.